Grants and Contributions:
Title:
KABS Facilities Expansion Project
Agreement Number:
815813
Agreement Value:
$36,657,400.00
Agreement Date:
May 1, 2020 - Mar 31, 2026
Description:
This project will support the expansion of a biomanufacturing facility St-Hubert (QC) and establishment of a new facility in Val-des-Sources (QC). The company will be able to produce monoclonal antibody therapies in Val-des-Sources then fill and package them in St-Hubert
Organization:
Innovation, Science and Economic Development Canada
Expected Results:
This investment will allow the expansion of GMP compliant bio-manufacturing capacity to 30 million liquid vials per year.
Location:
Longueuil, Quebec, CA J3Y9G2
Reference Number:
033-2020-2021-Q4-815813
Agreement Type:
Other transfer payment
Report Type:
Grants and Contributions
Recipient Business Number:
880752282
Recipient Type:
For-profit organization
Additional Information:
The amendment has been completed to reduce the contribution amount from $54.2M to $36.7M and extend the project timeline from July 2, 2047 to July 2, 2050. This is a repayable contribution.
Amendment Date
Jul 5, 2023
Recipient's Operating Name:
KABS Laboratories Inc.
Recipient's Legal Name:
KABS Laboratories Inc.
Federal Riding Name:
Longueuil--Saint-Hubert
Federal Riding Number:
24043
Program:
SIF Stream2- Growth
Program Purpose:
-Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.
NAICS Code:
325410
Amendments: